Abstract Library

#3823 Added value of post 177Lu Dotatate and Ga PET/CT imaging in prediction and evaluation of treatment response for GEP NETs

Introduction: Theragnostic approach using 68Ga Dota-peptides (PET) for diagnosis and Lutetium-177 Dotatate (Lutate) for therapy is approved in gastroenteropancreatic neuroendocrine tumors (GEP-NET). The 24-hour post-Lutate treatment imaging (Lutate post tp) evaluates the radiotracer distribution.

Conference:

Presenting Author: Abenavoli E

Authors: Abenavoli E, Linguanti F, Briganti V, Antonuzzo L, Mungai F,

Keywords: Lutetium-177 Dotatate, 68Ga-Dota peptide, evaluation response, prediction response, imaging parameter,

#3822 68Ga-DOTA peptides PET/CT radiomics in differentiation between pancreatic NET from physiologic uncinate process uptake

Introduction: 68Ga-DOTA peptides PET/CT (PET/CT) is the gold standard for neuroendocrine tumors detection (NET), which are often localized in the pancreas. Physiological uptake of pancreatic uncinate process (UP) is a known false positive site in almost of patients.

Conference:

Presenting Author: Linguanti F

Authors: Linguanti F, Abenavoli E, Briganti V, Mungai F, Antonuzzo L,

Keywords: 68Ga-Dota peptide, PET/CT, pancreas, neuroendocrine tumor, pNET,

#3207 What role for the interim PET/CT with 68Ga-DOTA peptides in the evaluation of the early response to PRRT?

Introduction: Early evaluation by PET/CT during therapy has an important predictive value of the final response in some tumors (e.g. lymphomas).

Conference: 18th Annual ENETS Concerence (2021)

Presenting Author:

Authors: Durmo R, Cervati V, Finocchiaro D, Filice A, Casali M,

Keywords: PRRT, PET/CT,